Overview
Roberta Camisa practices practicing medicine in Parma, Italy.
Her clinical expertise encompasses BRCA Positive Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Cancer.
She is actively involved in clinical research, co-authoring 18 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Roberta Camisa
Is Roberta Camisa a top-rated expert for BRCA Positive Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Roberta Camisa is classified as an Experienced expert for BRCA Positive Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Roberta Camisa participate in research or clinical trials?
Yes. Roberta Camisa has published 18 articles and abstracts on conditions like BRCA Positive Breast Cancer. You can view a list of Roberta Camisa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- BRCA Positive Breast CancerMs. Camisa isExperienced. Learn about BRCA Positive Breast Cancer.
- Lung CancerMs. Camisa isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Ms. Camisa isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).